Skip to main content

MoneyWorks4Me

Lupin informs about board meeting

04 May 2016 Evaluate

Lupin has informed that a meeting of the Board of Directors of the Company will be held on May 19, 2016, to consider and take on record the audited standalone and consolidated financial results for the year ended March 31, 2016 and recommend dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..